Skip to main content

Medtronic plc income statement

  • MDT · NYSE
  • Medical devices
  • Health Care Equipment
  • S&P 500
$102.86+1.85%Close 13 Nov 2026 · Market value $132.0B · Next results 24 Nov 2026

Medtronic plc reported revenue of $36.4 billion for fiscal year 2026 (the twelve months to 24 Apr 2026), up 8.4% from fiscal 2025. Net income was $4.80 billion and diluted earnings per share $3.73.

From Medtronic plc's annual and quarterly reports, each period checked against accounting identities; a figure that does not pass is left blank. Fiscal years follow the company's calendar, the latest ending 24 Apr 2026. TTM is the last four reported quarters added up.

Annual

Medtronic plc income statement, annual
USDFY 2013FY 2014FY 2015FY 2016FY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026TTM
Revenue$16.59B$17.00B$20.26B$28.83B$29.71B$29.95B$30.56B$28.91B$30.12B$31.69B$31.23B$32.36B$33.54B$36.36B$37.54B
Revenue growth—+2.5%+19.1%+42.3%+3.0%+0.8%+2.0%−5.4%+4.2%+5.2%−1.4%+3.6%+3.6%+8.4%—
Net interest income−$151.0M−$108.0M−$280.0M−$955.0M−$728.0M−$749.0M———$186.0M$386.0M$597.0M$511.0M$383.0M$365.0M
Cost of revenue$4.13B$4.33B$6.31B$9.14B$9.29B$9.07B$9.15B$9.42B$10.48B$10.14B$10.72B$11.22B$11.63B$12.72B$13.14B
Gross profit$12.46B$12.67B$13.95B$19.69B$20.42B$20.90B$21.40B$19.49B$19.63B$21.54B$20.51B$21.15B$21.91B$23.64B$24.41B
Gross margin75.1%74.5%68.9%68.3%68.7%69.8%70.0%67.4%65.2%68.0%65.7%65.3%65.3%65.0%65.0%
Selling, general and administrative$5.70B$5.85B$6.90B$9.47B$10.02B$10.24B$10.42B$10.11B$10.15B$10.29B$10.41B$10.74B$10.85B$11.78B$12.18B
Operating income$4.40B$3.81B$3.77B$5.36B$5.38B$6.64B$6.27B$4.79B$4.48B$5.75B$5.49B$5.14B$5.96B$6.47B$6.79B
Operating margin26.5%22.4%18.6%18.6%18.1%22.2%20.5%16.6%14.9%18.2%17.6%15.9%17.8%17.8%18.1%
Interest expense$388.0M$379.0M$666.0M$1.39B$1.09B$1.15B$1.44B$1.09B$925.0M$553.0M$636.0M$719.0M$729.0M$715.0M$724.0M
Other income and expense−$108.0M−$181.0M−$118.0M−$107.0M−$222.0M−$505.0M—————————
Income before tax$4.25B$3.71B$3.49B$4.34B$4.60B$5.67B$5.20B$4.05B$3.90B$5.52B$5.36B$4.84B$5.63B$6.14B$6.60B
Income tax expense$784.0M$640.0M$811.0M$798.0M$578.0M$2.58B$547.0M−$751.0M$265.0M$456.0M$1.58B$1.13B$936.0M$1.30B$1.33B
Effective tax rate18.4%17.3%23.3%18.4%12.6%45.5%10.5%−18.5%6.8%8.3%29.5%23.4%16.6%21.2%20.2%
Net income$3.47B$3.06B$2.67B$3.54B$4.03B$3.10B$4.63B$4.79B$3.61B$5.04B$3.76B$3.68B$4.66B$4.80B$5.23B
Net margin20.9%18.0%13.2%12.3%13.6%10.4%15.2%16.6%12.0%15.9%12.0%11.4%13.9%13.2%13.9%
Net income to common shareholders$3.47B$3.06B$2.67B$3.54B———————————
EPS · diluted$3.37$3.02$2.41$2.48$2.89$2.27$3.41$3.54$2.66$3.73$2.82$2.76$3.61$3.73$4.06
Diluted weighted average shares1.0B1.0B1.1B1.4B1.4B1.4B1.4B1.4B1.4B1.4B1.3B1.3B1.3B1.3B1.3B
Basic weighted average shares1.0B1.0B1.1B1.4B1.4B1.4B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
EBITDA$5.22B$4.66B$5.07B$8.18B$8.30B$9.28B$8.93B$7.45B$7.19B$8.46B$8.18B$7.79B$8.82B$9.43B$9.73B
EBITDA margin31.5%27.4%25.0%28.4%27.9%31.0%29.2%25.8%23.9%26.7%26.2%24.1%26.3%25.9%25.9%
Depreciation & amortization$819.0M$850.0M$1.31B$2.82B$2.92B$2.64B$2.66B$2.66B$2.70B$2.71B$2.70B$2.65B$2.86B$2.96B$2.94B
Stock-based compensation$152.0M$145.0M$439.0M$375.0M$348.0M$344.0M$290.0M$297.0M$344.0M$359.0M$355.0M$393.0M$429.0M$457.0M$496.0M
Dividends per share$1.04$1.12$1.22$1.52$1.72$1.84$2.00$2.16$2.32$2.52$2.72$2.76$2.80$2.84$2.85

Quarterly

Medtronic plc income statement, quarterly
USDQ2 FY2024Q3 FY2024Q4 FY2024Q1 FY2025Q2 FY2025Q3 FY2025Q4 FY2025Q1 FY2026Q2 FY2026Q3 FY2026Q4 FY2026Q1 FY2027
Revenue$7.98B$8.09B$8.59B$7.92B$8.40B$8.29B$8.93B$8.58B$8.96B$9.02B$9.81B$9.76B
Net interest income$148.0M$170.0M$168.0M$112.0M$137.0M$114.0M$147.0M$120.0M$89.00M$85.00M$89.00M$102.0M
Cost of revenue$2.76B$2.78B$3.04B$2.76B$2.95B$2.78B$3.15B$3.00B$3.06B$3.26B$3.40B$3.42B
Gross profit$5.22B$5.31B$5.54B$5.15B$5.46B$5.51B$5.78B$5.58B$5.90B$5.76B$6.41B$6.34B
Gross margin65.4%65.6%64.6%65.1%64.9%66.5%64.7%65.0%65.8%63.8%65.4%65.0%
Selling, general and administrative$2.69B$2.67B$2.77B$2.65B$2.76B$2.72B$2.72B$2.81B$2.96B$2.96B$3.06B$3.20B
Operating income$1.34B$1.48B$1.05B$1.28B$1.59B$1.65B$1.44B$1.45B$1.69B$1.46B$1.87B$1.76B
Operating margin16.8%18.3%12.3%16.1%19.0%19.9%16.1%16.8%18.8%16.2%19.1%18.1%
Interest expense$180.0M$188.0M$202.0M$167.0M$209.0M$179.0M$174.0M$176.0M$181.0M$181.0M$176.0M$186.0M
Income before tax$1.31B$1.47B$855.0M$1.27B$1.56B$1.54B$1.26B$1.30B$1.60B$1.40B$1.83B$1.77B
Income tax expense$402.0M$135.0M$197.0M$220.0M$281.0M$237.0M$199.0M$255.0M$215.0M$254.0M$575.0M$289.0M
Effective tax rate30.6%9.2%23.0%17.4%18.0%15.4%15.8%19.6%13.5%18.1%31.4%16.3%
Net income$909.0M$1.32B$654.0M$1.04B$1.27B$1.29B$1.06B$1.04B$1.37B$1.14B$1.24B$1.47B
Net margin11.4%16.3%7.6%13.2%15.1%15.6%11.8%12.1%15.3%12.7%12.7%15.1%
EPS · diluted$0.68$0.99$0.49$0.80$0.99$1.01$0.82$0.81$1.07$0.89$0.97$1.14
Diluted weighted average shares1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
Basic weighted average shares1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B1.3B
EBITDA$2.01B$2.13B$1.71B$1.94B$2.27B$2.33B$2.28B$2.19B$2.43B$2.21B$2.59B$2.49B
EBITDA margin25.2%26.4%19.9%24.5%27.0%28.1%25.5%25.6%27.1%24.5%26.4%25.6%
Depreciation & amortization$672.0M$649.0M$654.0M$662.0M$675.0M$684.0M$840.0M$748.0M$745.0M$749.0M$716.0M$729.0M
Stock-based compensation$146.0M$84.00M$90.00M$83.00M$159.0M$98.00M$89.00M$86.00M$182.0M$94.00M$95.00M$125.0M
Dividends per share$0.69$0.69$0.69$0.70$0.70$0.70$0.70$0.71$0.71$0.71$0.71$0.72

The main figures as JSON and plain text. See data and methodology.

MDT in the terminal

Every line back twenty years, charts of any figure, segments and KPIs by quarter, valuation and alerts.